{"id":400434,"date":"2025-06-14T01:05:00","date_gmt":"2025-06-13T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=400434"},"modified":"2025-05-15T11:18:34","modified_gmt":"2025-05-15T09:18:34","slug":"dreamm-7-belamaf-piu-bortezomib-e-desametasone-supera-la-terapia-di-confronto","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/dreamm-7-belamaf-piu-bortezomib-e-desametasone-supera-la-terapia-di-confronto\/","title":{"rendered":"DREAMM-7: Belamaf pi\u00f9 bortezomib e desametasone supera la terapia di confronto"},"content":{"rendered":"\n<p><strong>Nei pazienti con mieloma multiplo, la malattia \u00e8 spesso refrattaria alle terapie triple o quadruple di prima linea. Il risultato \u00e8 che si verifica una ricaduta. Pertanto, sono necessarie combinazioni efficaci di terapia di seconda linea che includano nuovi approcci terapeutici.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fdreamm-7-belamaf-piu-bortezomib-e-desametasone-supera-la-terapia-di-confronto%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Nei pazienti con mieloma multiplo, la malattia \u00e8 spesso refrattaria alle terapie triple o quadruple di prima linea. Il risultato \u00e8 che si verifica una ricaduta. Pertanto, sono necessarie combinazioni&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fdreamm-7-belamaf-piu-bortezomib-e-desametasone-supera-la-terapia-di-confronto%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":400436,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Mieloma multiplo","footnotes":""},"category":[11361,11519,11376,11550,11515],"tags":[60000,13872,28998,11951],"powerkit_post_featured":[],"class_list":["post-400434","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ematologia","category-formazione-continua","category-oncologia-it","category-rx-it","category-studi","tag-combinazione-di-terapie","tag-mieloma-multiplo","tag-refrattario","tag-terapia-di-seconda-linea","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-19 21:52:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":400426,"slug":"dreamm-7-belamaf-mais-bortezomib-e-dexametasona-tem-um-desempenho-superior-ao-da-terapeutica-comparadora","post_title":"DREAMM-7: Belamaf mais bortezomib e dexametasona tem um desempenho superior ao da terap\u00eautica comparadora","href":"https:\/\/medizinonline.com\/pt-pt\/dreamm-7-belamaf-mais-bortezomib-e-dexametasona-tem-um-desempenho-superior-ao-da-terapeutica-comparadora\/"},"es_ES":{"locale":"es_ES","id":400424,"slug":"dreamm-7-belamaf-mas-bortezomib-y-dexametasona-supera-al-tratamiento-de-comparacion","post_title":"DREAMM-7: Belamaf m\u00e1s bortezomib y dexametasona supera al tratamiento de comparaci\u00f3n","href":"https:\/\/medizinonline.com\/es\/dreamm-7-belamaf-mas-bortezomib-y-dexametasona-supera-al-tratamiento-de-comparacion\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/400434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=400434"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/400434\/revisions"}],"predecessor-version":[{"id":400437,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/400434\/revisions\/400437"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/400436"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=400434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=400434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=400434"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=400434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}